Holland & Knight has advised Saol Therapeutics. Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, has entered into a definitive agreement through which funds managed by...
Saol Therapeutics Secures Up to $115 Million Milestone-Based Financing from Oaktree Capital Management
Thryv Holdings Sells Print Directories Business to Carolwood for $142 Million
Holland & Knight has advised Thryv Holdings Inc. in the sale of its print directories business to Carolwood L.P. Sheppard has represented Carolwood L.P. Thryv Holdings...


























